GSK Plc (GSK)
50.45
-0.19
(-0.38%)
USD |
NYSE |
Nov 13, 16:00
50.46
+0.02
(+0.03%)
Pre-Market: 19:59
GSK Total Assets (Quarterly) : 95.25B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 95.25B |
| June 30, 2026 | 81.94B |
| March 31, 2026 | 82.91B |
| December 31, 2025 | 82.21B |
| September 30, 2025 | 82.58B |
| June 30, 2025 | 81.20B |
| March 31, 2025 | 78.35B |
| December 31, 2024 | 74.47B |
| September 30, 2024 | 77.86B |
| June 30, 2024 | 73.40B |
| March 31, 2024 | 73.91B |
| December 31, 2023 | 75.22B |
| September 30, 2023 | 74.29B |
| June 30, 2023 | 75.60B |
| March 31, 2023 | 72.45B |
| December 31, 2022 | 72.35B |
| September 30, 2022 | 67.33B |
| June 30, 2022 | 108.14B |
| March 31, 2022 | 79.19B |
| December 31, 2021 | 107.14B |
| September 30, 2021 | 106.10B |
| June 30, 2021 | 106.39B |
| March 31, 2021 | 107.73B |
| December 31, 2020 | 109.95B |
| September 30, 2020 | 104.62B |
| Date | Value |
|---|---|
| June 30, 2020 | 104.58B |
| March 31, 2020 | 104.63B |
| December 31, 2019 | 105.57B |
| September 30, 2019 | 102.58B |
| June 30, 2019 | 80.98B |
| March 31, 2019 | 81.26B |
| December 31, 2018 | 73.95B |
| September 30, 2018 | 76.42B |
| June 30, 2018 | 76.09B |
| March 31, 2018 | 78.78B |
| December 31, 2017 | 76.27B |
| September 30, 2017 | 78.87B |
| June 30, 2017 | 75.64B |
| March 31, 2017 | 74.07B |
| December 31, 2016 | 73.00B |
| September 30, 2016 | 76.36B |
| June 30, 2016 | 77.04B |
| March 31, 2016 | 78.30B |
| December 31, 2015 | 78.77B |
| September 30, 2015 | 80.46B |
| June 30, 2015 | 85.11B |
| March 31, 2015 | 86.10B |
| December 31, 2014 | 63.39B |
| September 30, 2014 | 65.34B |
| June 30, 2014 | 66.43B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AstraZeneca PLC | 114.02B |
| Johnson & Johnson | 197.42B |
| Eli Lilly & Co. | 148.07B |
| Merck & Co., Inc. | 132.77B |
| Novo Nordisk A/S | 91.04B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 70.86B |
| Shareholders Equity (Quarterly) | 24.91B |
| Debt to Equity Ratio | 1.264 |
| Current Ratio | 0.8637 |
| Net Debt Paydown Yield | -1.60% |